II
FOLD

Inspire Investing’s Amicus Therapeutics FOLD Stock Holding History

Inspire Investing’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$520K Buy
35,931
+2,656
+8% +$38.1K 0.03% 538
2025
Q4 		$474K Sell
33,275
-24,368
-42% -$239K 0.04% 361
2025
Q3 		$454K Sell
57,643
-10,607
-16% -$75.5K 0.04% 549
2025
Q2 		$391K Buy
68,250
+25,479
+60% +$164K 0.04% 468
2025
Q1 		$349K Sell
42,771
-380
-0.9% -$3.52K 0.04% 349
2024
Q4 		$406K Sell
43,151
-27,522
-39% -$286K 0.05% 372
2024
Q3 		$755K Buy
70,673
+35,431
+101% +$386K 0.08% 279
2024
Q2 		$350K Buy
35,242
+4,148
+13% +$42.6K 0.04% 678
2024
Q1 		$366K Buy
31,094
+3,422
+12% +$43.8K 0.04% 420
2023
Q4 		$393K Buy
27,672
+2,477
+10% +$28.1K 0.04% 421
2023
Q3 		$306K Buy
25,195
+95
+0.4% +$1.23K 0.04% 611
2023
Q2 		$315K Buy
25,100
+567
+2% +$6.73K 0.04% 472
2023
Q1 		$272K Buy
24,533
+4,981
+25% +$61.4K 0.03% 688
2022
Q4 		$239K Sell
19,552
-222
-1% -$2.5K 0.03% 365
2022
Q3 		$206K Buy
+19,774
New +$220K 0.03% 618

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Inspire Investing's FOLD Position: Q1 2026 in Review

Inspire Investing increased its Amicus Therapeutics (FOLD) stake by 8% in Q1 2026, buying an estimated $38.1K and bringing the position to 35,931 shares worth $520K. The position accounts for 0.03% of the portfolio, ranked #538.

Inspire Investing first reported a position in FOLD in Q3 2022 and has held it in 15 quarters since. The position peaked at $755K in Q3 2024. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Inspire Investing held 35,931 shares of Amicus Therapeutics worth $520K as of Q1 2026.
  • Inspire Investing bought 2,656 Amicus Therapeutics shares in Q1 2026, an estimated $38.1K.
  • Amicus Therapeutics made up 0.03% of Inspire Investing's portfolio in Q1 2026, its #538 holding.
  • Inspire Investing first reported a position in Amicus Therapeutics in Q3 2022 and has held it in 15 quarters since.
  • Inspire Investing's Amicus Therapeutics position peaked at $755K in Q3 2024.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Inspire Investing's 13F filing for Q1 2026, filed 23 Apr 2026.